Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-25T17:50:17.265Z Has data issue: false hasContentIssue false

A new day, a new treatment. A case report

Published online by Cambridge University Press:  01 September 2022

R. Galerón*
Affiliation:
Hospital Clínico San Carlos, Institute Of Psychiatry And Mental Health, Madrid, Spain
B. Serván
Affiliation:
Hospital Universitario Clínico San Carlos, Psychiatry And Mental Health, Madrid, Spain
M. Huete Naval
Affiliation:
Hospital Clínico San Carlos, Institute Of Psychiatry And Mental Health, Madrid, Spain
E. Herrero Pellón
Affiliation:
Hospital Clínico San Carlos, Institute Of Psychiatry And Mental Health, Madrid, Spain
P. Albarracin
Affiliation:
Hospital Universitario Clínico San Carlos, Psychiatry And Mental Health, Madrid, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

We present the case of a 21 year-old male, with history of a psychotic episode, currently with monthly follow-up in an outpatient facility, with a favorable clinical evolution after one year of intensive follow-up. In the context of abandonment of his medication and a problematic family situation, the patient starts to show suspicious, with insomnia and a progressive social isolation. Despite an attempt of ambulatory treatment with oral aripiprazole, showing good tolerance, the patient refuses such treatment, showing active clinical psychotic with great distress and behavioral repercussion, finally requiring hospital admission.

Objectives

To perform a literature review about the treatment initiation with two vials of aripiprazole long-acting injection.

Methods

Literature review of scientific articles using Pubmed as search engine. We considered articles published both in English and Spanish.

Results

During hospital stay, treatment with 2 intramuscular injections of 400mg of aripiprazole is started, combined with a single dose of oral aripiprazole 20mg on day 1, assuring correct dosing, with good tolerance and favoring therapeutic adherence. Progressively, the patient starts to feel calmer, adequate, collaborative and emotionally stable, recuperating chronobiological rhythms, with remission of the hallucinations and appearing more distant from delusions.

Conclusions

According to the currently available studies, the use of this posology could avoid the potential impact that lack of adherence to oral treatment could have in the therapeutic outcome, assuring a correct dosing and favoring adherence from day 1. Furthermore, this would help simplify the medication regiment for patients, physicians and caregivers.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.